Skinvisible, Inc.

Website Links

Description

Mr. McCartney is Chairman of the Board and Managing Director of Taylor Butterfield & Worth Asset Management Corporation, a privately held equities firm. He has held senior executive and director positions in five North American Exchange listed companies and is presently President of a privately held investment firm, Aspenwood Holdings Corporation. He has over 20 years of capital markets experience and has been instrumental in supporting the financial requirements for several small to medium sized businesses over a broad market sector. Mr.

Alto Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of unique products for maintaining a healthy lifestyle and improving quality of life.

Skinvisible Pharmaceuticals, Inc. (SKVI: OTCQB) is pleased to announce that is has successfully developed new additions to its sunless tanning product line formulated with its patented Invisicare ® polymer delivery technology. Skinvisible's sunless products address all of the issues which are common with sunless tanning products, specifically odor, streaking and the longevity of the tan.

Ms. McMorran brings to the Company almost 20 years of experience in the medical and pharmaceutical industry, specifically in the areas of strategic planning, sales and marketing. She has spent the last six years selling to international dermatology and skincare focused companies like Procter and Gamble, Johnson & Johnson, Stiefel, Galderma, Novartis and Graceway, to name a few. Ms. McMorran, who holds a Bachelor of Commerce (Honours) degree, spent six years in the pharmaceutical industry with Astra Pharma.

"The granting of this latest patent is fundamental to our intellectual property portfolio for Invisicare.

Fact sheet

Company contacts

Products & services

Similar companies nearby